prodisc C SK
Device
Centinel Spine, LLC
Total Payments
$2.1M
Transactions
274
Doctors
8
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $1.6M | 184 | 0 |
| 2020 | $483,059 | 90 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.1M | 265 | 98.9% |
| Consulting Fee | $23,688 | 5 | 1.1% |
| Travel and Lodging | $15.04 | 3 | 0.0% |
| Food and Beverage | $1.96 | 1 | 0.0% |
Payments by Type
Research
$2.1M
265 transactions
General
$23,705
9 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD) | Centinel Spine, LLC | $2.1M | 0 |
Top Doctors Receiving Payments for prodisc C SK
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Carmel, IN | $2.1M | 265 |
| , MD | Orthopaedic Surgery of the Spine | Flagstaff, AZ | $20,188 | 2 |
| , MD | Orthopaedic Surgery of the Spine | Matawan, NJ | $1,375 | 1 |
| , MD | Neurological Surgery | New York, NY | $1,375 | 1 |
| , M.D | Orthopaedic Surgery of the Spine | Plano, TX | $750.00 | 1 |
| , M.D | Orthopaedic Surgery | Baltimore, MD | $5.36 | 1 |
| , M.D | Neurological Surgery | Sacramento, CA | $4.84 | 1 |
| , MD | Orthopaedic Surgery | Southfield, MI | $4.84 | 1 |
| , MD | Neurological Surgery | Tampa, FL | $1.96 | 1 |
Ad
Manufacturing Companies
- Centinel Spine, LLC $2.1M
Product Information
- Type Device
- Total Payments $2.1M
- Total Doctors 8
- Transactions 274
About prodisc C SK
prodisc C SK is a device associated with $2.1M in payments to 8 healthcare providers, recorded across 274 transactions in the CMS Open Payments database. The primary manufacturer is Centinel Spine, LLC.
Payment data is available from 2020 to 2021. In 2021, $1.6M was paid across 184 transactions to 0 doctors.
The most common payment nature for prodisc C SK is "Unspecified" ($2.1M, 98.9% of total).
prodisc C SK is associated with 1 research study, including "A Multicenter, Prospective, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Prodisc C SK and Prodisc C Vivo to Mobi-C Cervical Disc in the Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD)" ($2.1M).